Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 5Thoracic 1Sarcoma 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Pancreatic Neoplasms 22Stomach Neoplasms 19Ovarian Neoplasms 18Colorectal Neoplasms 18Melanoma 15Carcinoma, Hepatocellular 15Carcinoma, Non-Small-Cell Lung 12Breast Neoplasms 11Neoplasm Metastasis 10Uterine Cervical Neoplasms 9Esophageal Neoplasms 9Liver Neoplasms 7Head and Neck Neoplasms 7Anus Neoplasms 7Colonic Neoplasms 6Carcinoma, Renal Cell 6Vaginal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Penile Neoplasms 5Neoplasms 5Mesothelioma 5Lung Neoplasms 5Cholangiocarcinoma 5Triple Negative Breast Neoplasms 4Oropharyngeal Neoplasms 4Neuroblastoma 4Gastrointestinal Neoplasms 4Carcinoma, Merkel Cell 4Vulvar Neoplasms 3Urinary Bladder Neoplasms 3

Interventions

pembrolizumab 10Paclitaxel 8Taxes 6Nivolumab 4Cyclophosphamide 4Cisplatin 4Carboplatin 4Polymerase Chain Reaction 3Irinotecan 3Interleukin-12 Subunit p35 3Docetaxel 3Bevacizumab 3sargramostim 2lenvatinib 2aldesleukin 2aflibercept 2Trastuzumab 2SS1(dsFv)PE38 2Radiotherapy 2Psychiatric Rehabilitation 2Methods 2Interleukin-12 2Gene Expression Profiling 2Gemcitabine 2Filgrastim 2Early Intervention, Educational 2Capecitabine 2Albumin-Bound Paclitaxel 2veliparib 1tocilizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × fludarabine × Gastrointestinal × Clear all
NCT04282044 2024-02-08

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

BioEclipse Therapeutics

Phase 1 Recruiting
60 enrolled
BreastDermatologicGastrointestinalGynecologicSarcomaThoracic

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Melanoma, Osteosarcoma, Stomach Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡